References
1. The Whole Country College Korean Medicine, Department of Singye Internal Medicine. Singye Internal Medicine Seoul: Koonja publishing co.; 2011. p. 310.
2. Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes 1999;7:245–52.
3. Kathleen M, Halat , Cathi E, Dennehy , Pharm D. Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy. J Am Board Fam Pract 2003;16(1):47–57.
4. Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab 1988;4:323–37.
5. Kaul CL, Ramarao P. The role of aldose reductase inhibitions in diabetic complications: recent trends. Methods Find Exp Clin Phamacol 2001;23:465–75.
6. Green DA, Lattimer SA, Sima AF. Sorbitol, phosphoinositides and sodium-potassium ATPase in the pathogenesis of diabetic complication. The New England Journal of medicine 1987;316(10):599–606.
7. Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetes. Muscle & Nerve 1988;11(1):21–32.
8. Kim JM, Cho CS, Kim CJ. Overview of Diabetic Peripheral Neuropathy and Need for Therapeutic Strategy using Traditional Korean Medicine. J Korean Oriental Med 2009;30(5):127–36.
9. Chen YS, Wu CH, YAO CH, Chen CT. Ginsenoside Rb-1 enhance peripheral nerve regeneration across wide gaps in silicone rubber chambers. Int J Artif Organ 2002;Nov. 25(11):1103–8.
10. Korean Diabetes Association, Group for Research on Neuropathy. Diabetic Neuropathy Seoul: Gold Gihoek; 2006. p. 172–3.
11. Kang SB. 2 case of Diabetic Neuropathy Treatments. J Korean Oriental Med 1992;13(2):22–5.
12. Park SW, Kang JK, Moon SK, Ko CN. Two experiences of the treatment for diabetic peripheral neuropathy. Journal of Korean Oriental Chronic Disease 1997;3(1):251–8.
13. Cho KH, Jung S, Lee KJ. A Case of Yukmijihwanghwan's effect on Diabetic neuropathy. Korean J. Orient. Int. Med 1999;20(1):286–90.
14. Kwon YK, Choi KR, Lee JS, Lee BC, Ahn YM, Ahn SY, et al. Two Cases of Diabetic Peripheral Polyneuropathy Improved by Bogan-tang. J Korean Oriental Med 2002;23(1):170–7.
15. Park SK, Kwon EH, Shin HC, Kang SB. One case of Diabetic Peripheral Polyneuropathy Improved by Binsosan-gamibang. J Korean Oriental Med 2005;26(4):935–40.
16. Choi HS, Cho CS, Kim CJ. Clinical Study on Two Cases of In patients with Diabetic Peripheral Neuropathy. Daejeon University Institute of korean medicine thesis Collection 2004;13(2):251–8.
17. Kim JM, Cho CS, Kim CJ. Clinical Study of 8 Diabetic Patients with Paresthesia. Korean J Orient Int Med 2010;31(2):184–91.
18. An SH. Effects of Bogijetong-tang treatment on animal model of peripheral neuropathy induced by Taxol and crush injury Doctoral Dissertation. Daejeon: Daejeon Univ; 2012.
19. Banker G, Goslin K. Culturing nerve cells MIT press; 2002.
20. Felderman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol 1999;12:553–63.
21. Verrotti A, Giuva PT, Morgese G, Chiarelli F. New trends in the etiopathogenesis of diabetic peripheral neuropathy. J Child Neurol 2001;16:389–94.
22. Stevens MJ, Felderman EL, Greene DA. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med 1995;12:566–79.
23. Greene DA, Lewis RA, Lattimer SA, Brown MJ. Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat. Diabetes 1982;31:573–8.
24. Greene DA, Sima AA, Stevens MJ, Felderman EL, Lattimer SA. Complication: neuropathy, pathogenetic consideration. Diabetes Cares 1992;15:1902–25.
25. Brownlee M, Vlassara H, Cerami A. Inhibition of heparin-catalyzed human antithrombin activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes. Diabetes 1984;33:532–5.
26. Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin induced diabetic rats. Diabetes 1995;44:234–42.
27. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995;18:1160–7.
28. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR. Effects of antioxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 1995;38:129–134.
29. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, et al. Prevention of abnormalities in motor nerve conduction and nerve bloodflow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats. Prostaglandins 1995;49:339–49.
30. Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997;2:S31–7.
31. Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR. A lipoic acid-gamma linolenic acid conjugate ie effective against multiple indices og experimental diabetic neuropathy. Diabetologia 1998;41:839–43.
32. A society for the research of Neuropathy in Korean Diabetes Association. Clinical practice of diabetic neuropathy 2nd edth ed. Seoul: Korean Diabetes Association; 2007. p. 1–48.
33. Doo HK. Internal medicine of kidney in oriental medicine Seoul: Institute of oriental medicine; 1991. p. 969–76.